<DOC>
	<DOCNO>NCT01996085</DOCNO>
	<brief_summary>Arterial hypertension ( AH ) important clinical social economic problem . In pathogenesis AH increase BP result complex mechanism i. e. fluid retention , increase vascular resistance hyperkinetic heart function . Impedance cardiography ( ICG ) simple safe , non-invasive method hemodynamic monitoring allow simultaneous assessment i. e. BP , cardiac index , heart rate , fluid content chest systemic vascular resistance . The detailed effect treatment base ICG evaluate far long-term observation clinically relevant parameter , central blood pressure , leave ventricular hypertrophy , metabolic disturbance , parameter antioxidative-oxidative balance endothelial function . Therefore , follow main objective study define : - Evaluation usefulness impedance cardiography optimize treatment patient hypertension area reduction control blood pressure , hemodynamic parameter , biochemical marker quality life . - Evaluation complex pathophysiological mechanism associate hypertension include hemodynamic , anthropometric , psychological biochemical parameter well effect antihypertensive treatment phenomenon . The study randomize ( 1:1 ) , prospective control parallel conventional treatment . The subject divide group accord pre-established random order : 1. empiric group ( GE ) , treatment choice base clinical data current guideline 2. hemodynamic group ( HD ) , treatment choice base clinical data current guideline consider hemodynamic parameter establish ICG method . All patient undergo detailed examination three time : treatment , 3 12 month treatment . The author expect study consolidate importance ICG diagnosis patient AH . Simultaneous multiparametric evaluation subject guarantee unique innovative result enhance knowledge pathophysiology AH reversibility adverse mechanism associate disease .</brief_summary>
	<brief_title>Non-invasive Haemodynamic Assessment Hypertension</brief_title>
	<detailed_description>THE IMPORTANCE OF THE PROJECT . Arterial Hypertension ( AH ) important clinical social economic problem major risk factor coronary artery disease , heart failure , kidney failure stroke . The risk organ damage significantly reduce achieve proper control blood pressure ( BP ) . In pathogenesis AH increase BP result complex mechanism i. e. fluid retention , increase vascular resistance hyperkinetic heart function . Impedance cardiography ( ICG ) simple safe , non-invasive method hemodynamic monitoring allow simultaneous assessment i. e. BP , cardiac index , heart rate , fluid content chest systemic vascular resistance . The study conduct far ( include applicant 's study ) demonstrate ICG provide good selection drug dose short-term observation . The detailed effect treatment strategy evaluate far long-term observation clinically relevant parameter , central blood pressure , leave ventricular hypertrophy , pulse wave velocity , metabolic disturbance , parameter antioxidative-oxidative balance endothelial function . Undoubtedly , evaluation may high importance evaluate complex pathophysiological mechanism associate cardiovascular hemodynamics . It expect result study perform group represent large population hypertensive patient allow highly objective , multiparametric evaluation usefulness ICG hypotensive therapy . The conclusion may clinically , socially economically important , especially term effectiveness continuity treatment patient AH primary prevention cardiovascular event organ damage . THE CONCEPT AND STUDY DESIGN . The main aim : 1 . Evaluation usefulness impedance cardiography optimize treatment patient hypertension area reduction control blood pressure , hemodynamic parameter , biochemical marker quality life . 2 . Evaluation complex pathophysiological mechanism associate hypertension include hemodynamic , anthropometric , psychological biochemical parameter well effect antihypertensive treatment phenomenon . The specific aim : 1 . Evaluation add value algorithm treatment base ICG optimize treatment patient AH reduction control BP , hemodynamic , biochemical marker quality life . 2 . Optimization use algorithm antihypertensive treatment basis multiparametric clinical evaluation . 3 . Determination hemodynamic profile patient AH include multiparametric clinical evaluation . 4 . Evaluation complex pathophysiological mechanism associate AH include hemodynamic , anthropometric , psychological biochemical parameter . 5 . Evaluation impact antihypertensive treatment value study haemodynamic anthropometric parameter , biochemical marker quality life . The study randomize ( 1:1 ) , prospective control parallel conventional treatment . Study group involve 140 patient sex , age 18 75 year . All patient undergo detailed examination three time : treatment , 3 12 month treatment , accord follow protocol . Qualification visit . Clinical assessment consideration criterion inclusion exclusion . Presentation information project . First visit ( qualification ) : - physical examination particular attention factor cardiovascular risk , include BP measurement accordance recommendation , - standard 12-lead electrocardiogram , - echocardiography , - 6-minute walk test ( 6-MWT ) , - impedance cardiography ( ICG ) , - measurement central blood pressure applanation tonometry , - measurement ankle-brachial index ( ABI ) , - ambulatory blood pressure measurement ( ABPM ) , - assessment brachial artery vasodilatation ischemia ( FMD ) , - laboratory test [ wide range ] , - psychological testing , - anthropometry , - assessment hemodynamics retrobulbar vessel use color Doppler imaging ( CDI ) - cardiovascular risk assessment - base examination result laboratory test . At first visit antihypertensive therapy non-pharmacological treatment ( individualized diet , weight reduction , regular physical activity , cease smoking ) recommend . The subject divide group accord pre-established random order ( www.randomization.com ) : 1. empiric group ( GE ) , treatment choice base clinical data current guideline ; 2. hemodynamic group ( HD ) , treatment choice base clinical data current guideline consider hemodynamic parameter establish ICG method . The choice treatment GE group perform research team member blind ICG result . The subject inform type intervention use . The randomization study group - first visit - maintain visit . Depending value SVRI , CI , HR TFC , hemodynamic disturbance define : ( 1 ) hemodynamic profile excessive vasoconstriction ( hyperconstrictive , C : case SVRI &gt; 2500 dyn•s•cm-5•m2 ) , ( 2 ) hyperdynamic heart function ( hyperdynamic , D : CI &gt; 4.2 l/min/m2 and/or HR &gt; 80/min ) , ( 3 ) characteristic overhydration ( hypervolemic , V : man - TFC &gt; 34 1/kOhm ; woman - TFC &gt; 24 1/kOhm ) , ( 4 ) balance hemodynamic profile balance ( B , hemodynamic parameter threshold predefined ) - angiotensin convert enzyme inhibitor indicate . In STEP 1 , patient 's hemodynamic profile hyperdynamic - beta-blocker recommend , hypervolemic -diuretic , hyperconstrictive - angiotensin convert enzyme inhibitor angiotensin receptor blocker ( systemic vascular resistance index &gt; 2800 dyn•s•cm-5•m2 - angiotensin convert enzyme inhibitor/angiotensin receptor blocker calcium blocker recommend ) . In case complex hemodynamic disturbance combine therapy apply . The STEP 2 reserve patient relatively high blood pressure ( expect reduction ≥ 20/10mmHg , 24-h mean BP ≥ 140/90 mmHg ) impedance cardiography suggest one hemodynamic disturbance . They assume demand polytherapy reason second drug add first chosen STEP 1 combination : 1. beta-blocker angiotensin convert enzyme inhibitor/angiotensin receptor blocker ; 2. angiotensin convert enzyme inhibitor/angiotensin receptor blocker diuretic ; 3. diuretic angiotensin convert enzyme inhibitor/angiotensin receptor blocker . Second visit ( 3 month pharmacotherapy ) : - physical examination particular attention factor cardiovascular risk , include BP measurement accordance recommendation , - impedance cardiography ( ICG ) , - measurement central blood pressure applanation tonometry , - ambulatory blood pressure measurement ( ABPM ) , - laboratory test [ narrow range ] , - psychological testing , - anthropometry - cardiovascular risk assessment - base examination result laboratory test . Third visit ( 9 month second visit , case hospitalization cardiovascular reason ) : range examination test first visit , In course observation , patient right contact research team initiative question concern related participation study health condition . CHARACTERISTICS OF THE MAIN APPLIED RESEARCH METHODS . Laboratory test perform Department Laboratory Diagnostics Military Medical Institute : 1 . [ wide range ] : blood count , ionogram , creatinine , urea , uric acid , alanine aminotranserase aspartate aminotranserase , creatine kinase ( CK , CK-MB ) , lipid profile : total cholesterol , LDL HDL cholesterol , triglyceride , fast glucose , insulin , glycosylated hemoglobin ( HbA1C ) , lipoprotein ( ) , leptin , adiponectin ; urinalysis , microalbuminuria , homocysteine ; high sensitive C-reactive protein ( hsCRP ) , coagulogram , fibrinogen , D-dimer , superoxide dismutase , plasminogen activator inhibitor 1 , resistin 2 . [ narrow range ] : blood count , ionogram , creatinine , urea , lipid profile , fast glucose Impedance cardiography ( ICG ) . On basis 10-minute rest recording ICG detail analysis mean value hemodynamic parameter perform : systolic blood pressure ( SBP ) , mean blood pressure ( MBP ) , diastolic blood pressure ( DBP ) , pulse pressure ( PP ) , heart rate ( HR ) , stroke volume ( SV ) index ( SI ) , cardiac index ( CI ) , systemic vascular resistance index ( SVRI ) , total artery compliance ( TAC ) characteristic aortic flow : velocity index ( VI ) acceleration index ( ACI ) . Final assessment also include spectral variability hemodynamic parameter ( i. e. HR , CI , SV , SVR ) . Central blood pressure measurement ( applanation tonometry ) . Non-invasive assessment central blood pressure relate parameter perform use method applanation tonometry ( SphygmoCor Px Aortic BP Profile System ) . The parameter derive aortic blood pressure waveform analysis i.e . aortic augmentation index ( AAI ) , central blood pressure ( CBP ) central pulse pressure ( CPP ) analyze . Ambulatory blood pressure monitoring ( ABPM ) . All patient include study undergo ABPM ( Spacelabs 90207 ; Spacelabs , Medical Inc , Redmond , Washington , USA ) . The average value SBP , MBP , DBP , PP ( derive 24-h period , daytime nightime period ) correspond standard deviation ( SD ) analyze . As minimum acceptable number valid BP measurement 70 % assume . Echocardiography . Echocardiography perform accord current standard use Vivid 7 apparatus ( GE-Healthcare , USA ) . Measurements connect size heart chamber , contractility leave ventricle wall thickness , ejection fraction leave ventricle relaxation disorder evaluate record . The examination also include automated functional imaging ( AFI ) leave ventricle . Flow-mediated dilatation ( FMD ) . The measurement perform morning , quiet room 10 minute rest supine position . Evaluation brachial artery do 2-D projection , 3-5 cm cubital fossa , Doppler linear probe frequency 8 MHz . Dilation brachial artery ischemia express percentage change brachial artery diameter induce ischemia relation diameter vessel prior ischemia , accordance generally accept methodology . Color Doppler Imaging ( CDI ) retrobulbar vessel ophthalmic examination Evaluation retrobulbar vessel ( ophthalmic artery OA , central retinal artery CRA short posterior ciliary artery ( temporal nasal ) TSPCA , NSPCA ) randomly select eye do Doppler linear probe frequency 6-15 MHz ( LOGIQ 9 Color Doppler Imaging System ; General Electric Medical Systems , Milwaukee , Wisconsin , USA ) include assessment peak systolic velocity ( PSV ) , end diastolic velocity ( EDV ) resistance index ( RI ) calculate follow : RI = ( PSV -EDV ) /PSV . All subject underwent also randomly select eye examination include : autorefractometry air-puff tonometry ( TRK-1P , TOPCON Corporation , Tokyo , Japan ) , slit-lamp stereo optic disc evaluation Spectral optical coherence tomography ( OCT/SLO ) ( Ophthalmic Technologies , Inc. OTI , Toronto , ON , CANADA ) optic nerve head ( ONH ) , retinal nerve fiber layer ( RNFL ) macula . DATA ANALYSIS . All result archive form extensive database possibility multiple analysis , use advanced data analysis system , Statistica , SPSS , MedCalc . To evaluate complex pathophysiological mechanism associate hypertension include hemodynamic , anthropometric , psychological biochemical parameter ( well effect antihypertensive treatment phenomenon ) correlation inter-subgroups comparison perform . The result detail ophthalmic examination also refer cardiovascular assessment . MEASURABLE DOCUMENTED EFFECT OF THE PROBLEM . The author expect study form basis substantive merit implement propose algorithm hemodynamic assessment broad clinical practice tool support optimization hypotensive therapy . It expect result consolidate importance ICG diagnosis patient AH . Simultaneous multiparametric evaluation subject guarantee unique innovative result enhance knowledge pathophysiology AH reversibility adverse mechanism associate disease . It may become inspiration undertake clinical trial related practical application new method hemodynamic monitoring .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Indapamide</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<criteria>untreated AH ( elevate BP value ≥ 3 month ) insufficiently control AH one two antihypertensive drug . confirm secondary AH , improperly control AH three medicine chronic renal failure third high stage disease , severe concomitant disease : systolic heart failure , cardiomyopathy , significant cardiac arrhythmia , significant valvular disease , chronic obstructive pulmonary disease ( stage C/D ) , diabetes , previously undetected , polyneuropathy , peripheral vascular disease , body mass index ( BMI ) &gt; 40 kg/m2 , mental illness , prevent cooperation physician , heart rhythm sinus ( include , i.e . constant heart stimulation ) ,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>arterial hypertension</keyword>
	<keyword>hemodynamics</keyword>
	<keyword>impedance cardiography</keyword>
	<keyword>hypotensive therapy</keyword>
</DOC>